Intelligent Oxygen Therapy During Activities of Daily Living
The Assessment of Intelligent Oxygen Therapy (iO2T) in Patients on Long-term Oxygen Therapy During Activities of Daily Living
1 other identifier
interventional
25
1 country
1
Brief Summary
The aim of this study is to assess whether an auto-titrating oxygen system can maintain constant oxygen saturations (SpO2) in patients who are on long-term oxygen therapy (LTOT) during activities of daily living. Currently LTOT is provided at a constant fixed-flow rate e.g. 2 litres per minute all the time after appropriate assessment. The flow rate is not changed during usual household activities but is increased for walking. A number of studies have investigated the SpO2 of patients on LTOT during the daytime in patients' homes. The results have shown that patients' SpO2 decreases intermittently whilst they are doing activities of daily living such as watching television, putting away the shopping, having a shower or bath and dressing and undressing. This is a problem as it can lead to breathlessness, increased stress on the heart and affect brain function. In order to correct the drop in SpO2 that patients experience during everyday activities, the investigators have developed an oxygen system, which can automatically change the amount of oxygen delivered depending on a patients' oxygen saturations - an auto-titrating oxygen system. In this study, patients on LTOT will be asked to simulate a series of activities of daily living twice: once whilst on their usual fixed-flow oxygen therapy and once on the auto-titrating oxygen system. The activities will be carried out in a hospital setting. During the activities, SpO2 will be recorded continuously. The main outcome of interest from the study will be the SpO2 throughout the study on fixed-flow oxygen and the auto-titrating oxygen system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 26, 2016
CompletedFirst Posted
Study publicly available on registry
February 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2017
CompletedNovember 29, 2023
November 1, 2023
1 year
January 26, 2016
November 23, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The percentage of time spent with SpO2 <90% during the activities of daily living - 55 minutes
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Secondary Outcomes (4)
Mean SpO2 during the activities of daily living - 55 minutes
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Mean Heart rate during the activities of daily living - 55 minutes
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Borg score for breathlessness and fatigue at the end of activities of daily living (55 minutes)
At the end of activities of daily living (55 minutes)
Total volume of oxygen delivered during simulated activities of daily living during the activities of daily living (55 minutes)
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Study Arms (2)
Activities of daily living on iO2t
EXPERIMENTALPatients will complete simulated activities of daily living on intelligent oxygen therapy (an auto-titrating oxygen system)
Activities of daily living on LTOT
ACTIVE COMPARATORPatients will complete activities of daily living on their usual long-term oxygen therapy.
Interventions
This device is an auto-titrating oxygen system. The system is programmed to maintain a specific target SpO2 by automatically adjusting the oxygen flow rate. The system can deliver flow rates of 0-5 litres/minute.
This is the patients usual long-term oxygen therapy
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Currently on or eligible for LTOT for respiratory failure
You may not qualify if:
- LTOT flow rate ≥4 litres per minute
- Exacerbation of underlying lung disease in the past 4 weeks
- Inability to understand English
- Significant co-morbidities
- Patients who lack capacity to consent
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Brompton and Harefield NHS Trust
London, SW3 6NP, United Kingdom
Related Publications (1)
Mohammad Moghal, Rishi Goburdhun, Mary Morrell, Robert Dickinson, Anita Simonds A Novel Smartphone Based Auto-Titrating Oxygen System Reduces Intermittent Hypoxia During Activities of Daily Living in Patients on Long-Term Oxygen Therapy. American Journal of Respiratory and Critical Care Medicine 2017;195:A7709
RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anita Simonds, FRCP
Royal Brompton & Harefield NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2016
First Posted
February 17, 2016
Study Start
January 1, 2016
Primary Completion
January 1, 2017
Study Completion
January 15, 2017
Last Updated
November 29, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share